| CPC A61K 31/28 (2013.01) [A61P 35/00 (2018.01)] | 3 Claims |
|
1. A method of treating a cancer patient comprising administering at least one dose of [RuCl3(dimethylsulfoxide)(3,5-dimethylpyrazole)2] to the cancer patient, wherein the cancer patient has a non-small cell lung cancer subtype.
|